We are delighted to present our Week 52 long-term follow up data at WCIRDC, a meeting renowned for showcasing exciting advances in diabetes and metabolic research,” said Mick Hitchcock, Ph.D., Interim ...

The abstract will be published in the peer-reviewed Metabolism: Experimental and Clinical. The presentation will be available on Biomea Fusion's Investor Relations Page under the Events. Please find a ...

Novo Nordisk continues to pioneer obesity innovation, including presentation of full Phase 3 REDEFINE 1 and 2 trial results, providing insights into the transformational potential of CagriSema ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The tool predicts changes in A1C in the next 90 days and ...

CHICAGO, June 21, 2025 (GLOBE NEWSWIRE) -- Abvance Therapeutics, a biotechnology company developing next generation glucagon analogs and therapies to prevent hypoglycemia and improve glucose ...

After working to make its continuous glucose monitoring systems compatible with the major players in the diabetes device industry, Dexcom is opening its doors much wider. With an FDA blessing for ...

(RTTNews) - Insulet Corp. (PODD) said that Omnipod 5 Automated Insulin Delivery System, the world's first tubeless, wearable system that continuously adapts insulin delivery based on glucose levels ...

CHICAGO — Although recent trials indicate intensive lipid-lowering therapy is advantageous for patients with diabetes, specific LDL targets remain elusive, according to a presentation at the American ...

Fractyl Announces New Clinical Data on the Mechanism of Revita DMR in Type 2 Diabetes Data presented at ENDO 2020 from the randomized, sham-controlled REVITA-2 study verifies that improvements in ...

BOSTON--(BUSINESS WIRE)--This week Onduo presented research results at the American Diabetes Association’s (ADA) 80th Scientific Sessions: A Virtual Experience demonstrating continued and meaningful ...